VLDLR-AS1: A Potential Drug Target and Biomarker (G401491)

Target Name: VLDLR-AS1

NCBI ID: G401491

VLDLR-AS1

Other Name(s): VLDLR antisense RNA 1 | lincRNA-VLDLR | linc-VLDLR

VLDLR-AS1: A Potential Drug Target and Biomarker

VLDLR-AS1 (VLDLR antisense RNA 1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. VLDLR is a gene that encodes a protein known as VLDLR, which is involved in the regulation of mitochondrial function and energy metabolism. The VLDLR gene has been associated with a number of cellular processes, including the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

The Identification of VLDLR-AS1 as a Potential Drug Target

One of the reasons why VLDLR-AS1 has generated so much interest is its potential as a drug target. The VLDLR protein has been shown to play a role in a variety of cellular processes, including the regulation of mitochondrial function, cell survival, and metabolism. It is possible that targeting VLDLR-AS1 with small molecules or other therapeutic agents could lead to the development of new treatments for a variety of diseases.

In addition to its potential as a drug target, VLDLR-AS1 has also been identified as a potential biomarker. The VLDLR gene has been shown to be expressed in a variety of tissues and cells, including cancer cells, neurons, and heart cells. This suggests that VLDLR-AS1 could be a useful biomarker for the diagnosis and treatment of diseases associated with VLDLR gene expression.

The Function of VLDLR and VLDLR-AS1

VLDLR is a protein that is expressed in a variety of tissues and cells and is involved in the regulation of mitochondrial function and energy metabolism. It is composed of multiple domains, including an N-terminal transmembrane domain, a coiled-coil domain, and a C-terminal T-cell receptor (TCR) domain. The TCR domain is responsible for the interaction of VLDLR with other molecules, including DNA and proteins.

The VLDLR protein has been shown to play a role in a variety of cellular processes, including the regulation of mitochondrial function, cell survival, and metabolism. It is involved in the transfer of electrons from the mitochondria to the cytoplasm, which is necessary for the proper functioning of the cell. It is also involved in the regulation of cellular energy metabolism, including the burning of glucose to produce energy.

In addition to its role in energy metabolism, VLDLR has also been shown to play a role in the regulation of cell survival. It is involved in the regulation of cell cycle progression, which is the process by which cells grow and divide. VLDLR has been shown to play a role in the regulation of the G1/S transition, which is the stage of the cell cycle where the cell prepares for cell division.

The Expression of VLDLR in Different Tissues and Cells

VLDLR is expressed in a variety of tissues and cells, including cancer cells, neurons, and heart cells. It is highly expressed in the brain, where it is involved in the regulation of neural cell survival and function. It is also expressed in other tissues, including the lungs, liver, and heart.

In addition to its expression in different tissues, VLDLR has also been shown to be involved in a variety of cellular processes. It is involved in the regulation of mitochondrial function, cell survival, and metabolism. It is also involved in the regulation of the transfer of electrons from the mitochondria to the cytoplasm, which is necessary for the proper functioning of the cell.

VLDLR-AS

Protein Name: VLDLR Antisense RNA 1

The "VLDLR-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VLDLR-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets